Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

benzene/obesitas

Tautan disimpan ke clipboard
Halaman 1 dari 17 hasil

Benzene compounds

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to benzene compounds, and more particularly, to novel benzene compounds having inhibition activity on acetyl CoA carboxylase ("ACC" hereinafter). 2. Discussion of the Background It has become clear in recent years

2-alkyloxy benzene formyl arylamine compound and pharmaceutical use thereof

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD The present invention belongs to the field of medicinal chemistry, which is about the 2-alkoxy benzene formyl arylamine compounds and their pharmaceutical uses, especially the 2-alkoxy benzene formyl arylamine compounds and their uses in preparing sphingomyelin synthase inhibitors,

Lipoprotein lipase-activating compositions comprising benzene derivates

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD The present invention relates to compositions for activating lipoprotein lipase (hereinafter referred to as "LPL") and benzene compounds. The invention is further directed to the use of compounds activating LPL for preparing LPL-activating compositions, and a method for activating

Substituted benzene compounds as modulators of the glucocorticoid receptor

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
PRIORITY TO RELATED APPLICATION(S) This application claims the benefit of European Patent Application No. 09156260.3, filed Mar. 26, 2009, which is hereby incorporated by reference in its entirety. BACKGROUND OF THE INVENTION Glucocorticoids are responsible for several physiological functions

1,1'-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION The present invention is related to carboxylic acids of formula (I), in particular for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance,

Fused heterocyclic compounds

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION The present invention relates to compounds and compositions useful in the treatment of conditions and disorders associated with eating behavior, energy homeostasis and anxiety. BACKGROUND OF THE INVENTION G-protein coupled receptors play important roles in diverse signaling

Benzoxathiin derivative

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
CROSS REFERENCE TO RELATED APPLICATIONS This application is a U.S. National Phase application under 35 U.S.C. .sctn.371 of PCT Application No. PCT/JP2006/321813, filed Oct. 25, 2006, which claims priority under 35 U.S.C. .sctn.119 from JP Application No. JP2005-312956, filed Oct. 27, 2005. TECHNICAL

Spiro imidazoline compounds

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION The present invention relates to new Spiro imidazoline compounds, and to their use as .alpha.2-adrenergic antagonists and monoamine reuptake blockers. DESCRIPTION OF THE PRIOR ART AND BACKGROUND OF THE INVENTION The adrenergic nervous system plays an important role at a number

Melanin-concentrating hormone antagonist

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is the National Phase filing of International Patent Application No. PCT/JP01/04015, filed 15 May 2001. TECHNICAL FIELD The present invention relates to a melanin-concentrating hormone antagonist which is useful as an agent for preventing or treating obesity, etc. BACKGROUND

Aromatic heterocyclic compound

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD The present invention relates to an aromatic heterocyclic compound or a pharmaceutically acceptable salt thereof having an acylcoenzyme A: diacylglycerolacyltransferase (DGAT) 1 inhibitory activity. BACKGROUND ART Obesity is a condition wherein fat is excessively accumulated in a

Aromatic heterocyclic compound

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD The present invention relates to an aromatic heterocyclic compound or a pharmaceutically acceptable salt thereof having an acylcoenzyme A: diacylglycerolacyltransferase (DGAT) 1 inhibitory activity. BACKGROUND ART Obesity is a condition wherein fat is excessively accumulated in a

Azulene derivatives and salts thereof

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Phase Application based on PCT/JP2003/009868, filed on Aug. 4, 2003, the content of which is incorporated herein by reference, and claims the priority of Japanese Patent Application Nos. 2002-226869, filed on Aug. 5, 2002, and

Propanolamine derivative having 1, 4-benzodioxane ring

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is a 371 of PCT/JP01/07951 filed Sep. 13, 2001. TECHNICAL FIELD This invention relates to novel propanolamine derivatives having a 1,4-benzodioxane ring and medicaments containing them as active ingredients. The derivatives are useful as prophylactic or therapeutic agents for

3-hydroxy-5-arylisoxazole derivative

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD The present invention relates to a compound for modulationg the functions of G protein-coupled receptor 40 (GPR40). In particular, the present invention relates to a 3-hydroxy-5-arylisoxazole compound of Formula (I), a salt of the compound, a solvate of the compound or the salt, a

3-hydroxy-5-arylisothiazole derivative

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD The present invention relates to a compound for modulating the functions of G protein-coupled receptor 40 (GPR40). In particular, the present invention relates to a compound having a 3-hydroxy-5-arylisothiazole ring of Formula (I), a salt of the compound, a solvate of the compound or
Bergabunglah dengan
halaman facebook kami

Database tanaman obat terlengkap yang didukung oleh sains

  • Bekerja dalam 55 bahasa
  • Pengobatan herbal didukung oleh sains
  • Pengenalan herbal melalui gambar
  • Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
  • Baca publikasi ilmiah yang terkait dengan pencarian Anda
  • Cari tanaman obat berdasarkan efeknya
  • Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten

Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan

Google Play badgeApp Store badge